139 related articles for article (PubMed ID: 36194016)
1. Outcomes of Critically Ill Children With Acute Lymphoblastic Leukemia and Cytokine Release Syndrome Due to Chimeric Antigen Receptor T Cell Therapy: US, Multicenter PICU, Cohort Database Study.
Logan GE; Miller K; Kohler ME; Loi M; Maddux AB
Pediatr Crit Care Med; 2022 Dec; 23(12):e595-e600. PubMed ID: 36194016
[TBL] [Abstract][Full Text] [Related]
2. Renal Replacement Therapy Modalities in Critically Ill Children.
Beltramo F; DiCarlo J; Gruber JB; Taylor T; Totapally BR
Pediatr Crit Care Med; 2019 Jan; 20(1):e1-e9. PubMed ID: 30334906
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and outcome of Chimeric Antigen Receptor T-Cell patients admitted to Pediatric Intensive Care Unit: CART-PICU study.
Caballero-Bellón M; Alonso-Saladrigues A; Bobillo-Perez S; Faura A; Arqués L; Rivera C; Català A; Dapena JL; Rives S; Jordan I
Front Immunol; 2023; 14():1219289. PubMed ID: 37600775
[TBL] [Abstract][Full Text] [Related]
4. Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia.
Fitzgerald JC; Weiss SL; Maude SL; Barrett DM; Lacey SF; Melenhorst JJ; Shaw P; Berg RA; June CH; Porter DL; Frey NV; Grupp SA; Teachey DT
Crit Care Med; 2017 Feb; 45(2):e124-e131. PubMed ID: 27632680
[TBL] [Abstract][Full Text] [Related]
5. Renal Replacement Therapy in the Critically Ill Child.
Westrope CA; Fleming S; Kapetanstrataki M; Parslow RC; Morris KP
Pediatr Crit Care Med; 2018 Mar; 19(3):210-217. PubMed ID: 29315136
[TBL] [Abstract][Full Text] [Related]
6. ICU-Acquired Weakness Is Associated With Differences in Clinical Outcomes in Critically Ill Children.
Field-Ridley A; Dharmar M; Steinhorn D; McDonald C; Marcin JP
Pediatr Crit Care Med; 2016 Jan; 17(1):53-7. PubMed ID: 26492063
[TBL] [Abstract][Full Text] [Related]
7. Functional Outcomes at 1 Year After PICU Discharge in Critically Ill Children With Severe Sepsis.
Sankar J; Moodu S; Kumar K; Sankar MJ; Kabra SK; Lodha R
Pediatr Crit Care Med; 2021 Jan; 22(1):40-49. PubMed ID: 33031352
[TBL] [Abstract][Full Text] [Related]
8. Neurologic and Functional Morbidity in Critically Ill Children With Bronchiolitis.
Shein SL; Slain KN; Clayton JA; McKee B; Rotta AT; Wilson-Costello D
Pediatr Crit Care Med; 2017 Dec; 18(12):1106-1113. PubMed ID: 28930814
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and Timing of Mortality in Children Dying With Infections in North American PICUs.
Johnson KT; Görges M; Murthy S
Pediatr Crit Care Med; 2021 Apr; 22(4):365-379. PubMed ID: 33591070
[TBL] [Abstract][Full Text] [Related]
10. Outcomes Analysis of Children Diagnosed With Hemophagocytic Lymphohistiocytosis in the PICU.
Gregory J; Greenberg J; Basu S
Pediatr Crit Care Med; 2019 Apr; 20(4):e185-e190. PubMed ID: 30520798
[TBL] [Abstract][Full Text] [Related]
11. Critically Ill Patients Treated for Chimeric Antigen Receptor-Related Toxicity: A Multicenter Study.
Gutierrez C; Brown ART; May HP; Beitinjaneh A; Stephens RS; Rajendram P; Nates JL; Pastores SM; Dharshan A; de Moraes AG; Hensley MK; Feng L; Brudno JN; Athale J; Ghosh M; Kochenderfer JN; Arias AS; Lin Y; McEvoy C; Mead E; Westin J; Kostelecky N; Mian A; Herr MM
Crit Care Med; 2022 Jan; 50(1):81-92. PubMed ID: 34259446
[TBL] [Abstract][Full Text] [Related]
12. Enteral Nutrition Practices in Critically Ill Children Requiring Noninvasive Positive Pressure Ventilation.
Leroue MK; Good RJ; Skillman HE; Czaja AS
Pediatr Crit Care Med; 2017 Dec; 18(12):1093-1098. PubMed ID: 28816919
[TBL] [Abstract][Full Text] [Related]
13. Educational Outcomes of Childhood Survivors of Critical Illness-A Population-Based Linkage Study.
Tomaszewski W; Ablaza C; Straney L; Taylor C; Millar J; Schlapbach LJ;
Crit Care Med; 2022 Jun; 50(6):901-912. PubMed ID: 35170536
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and Outcome of Critically Ill Pediatric Cancer and Hematopoietic Stem Cell Transplant Patients Requiring Continuous Renal Replacement Therapy: A Retrospective Nationwide Cohort Study.
Raymakers-Janssen PAMA; Lilien MR; Tibboel D; Kneyber MCJ; Dijkstra S; van Woensel JBM; Lemson J; Cransberg K; van den Heuvel-Eibrink MM; Wösten-van Asperen RM;
Crit Care Med; 2019 Nov; 47(11):e893-e901. PubMed ID: 31464768
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for acquiring functional and cognitive disabilities during admission to a PICU*.
Bone MF; Feinglass JM; Goodman DM
Pediatr Crit Care Med; 2014 Sep; 15(7):640-8. PubMed ID: 25072478
[TBL] [Abstract][Full Text] [Related]
16. Derivation and Validation of the Critical Bronchiolitis Score for the PICU.
Mount MC; Ji X; Kattan MW; Slain KN; Clayton JA; Rotta AT; Shein SL
Pediatr Crit Care Med; 2022 Jan; 23(1):e45-e54. PubMed ID: 34261942
[TBL] [Abstract][Full Text] [Related]
17. Development of a PICU in Nepal: the experience of the first year.
Basnet S; Shrestha S; Ghimire A; Timila D; Gurung J; Karki U; Adhikari N; Andoh J; Koirala J
Pediatr Crit Care Med; 2014 Sep; 15(7):e314-20. PubMed ID: 25080149
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the risk factors to predict cytokine release syndrome in relapsed or refractory B-cell acute lymphoblastic leukemia patients receiving IL-6 knocking down anti-CD19 chimeric antigen receptor T-cell therapy.
Gong WJ; Qiu Y; Li MH; Chen LY; Li YY; Yu JQ; Kang LQ; Sun AN; Wu DP; Yu L; Xue SL
Front Immunol; 2022; 13():922212. PubMed ID: 36105799
[TBL] [Abstract][Full Text] [Related]
19. Predictive role of endothelial cell activation in cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukaemia.
Hong F; Shi M; Cao J; Wang Y; Gong Y; Gao H; Li Z; Zheng J; Zeng L; He A; Xu K
J Cell Mol Med; 2021 Dec; 25(24):11063-11074. PubMed ID: 34734474
[TBL] [Abstract][Full Text] [Related]
20. Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children.
Srinivasan V; Spinella PC; Drott HR; Roth CL; Helfaer MA; Nadkarni V
Pediatr Crit Care Med; 2004 Jul; 5(4):329-36. PubMed ID: 15215001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
